Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Alcidion Group Limited ( (AU:ALC) ).
Alcidion Group Limited has announced an expansion of its contract with North Cumbria Integrated Care NHS Foundation Trust to include MediViewer, an Electronic Document Management System, into its Miya Precision Electronic Patient Record solution. This integration will provide seamless access to scanned and historical documents, enhancing clinical workflows and digital maturity. The contract, valued at approximately $6.8 million over 9.4 years, aligns with Alcidion’s strategy to support the digitization of healthcare workflows and improve patient care efficiency. The implementation of MediViewer is expected to drive regional convergence and efficiency, laying the groundwork for future adoption of emerging technologies like AI and predictive analytics.
The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is a healthcare technology company focused on transforming healthcare with smart, intuitive solutions that enhance the efficiency and quality of patient care globally. Their flagship product, Miya Precision, aggregates meaningful information to support interoperability, communication, and task management in clinical settings, aiming to improve patient outcomes. Since its ASX listing in 2016, Alcidion has expanded its presence in the UK, Australia, and New Zealand, serving over 400 hospitals and 87 healthcare organizations.
Average Trading Volume: 1,104,528
Technical Sentiment Signal: Buy
Current Market Cap: A$127.6M
See more insights into ALC stock on TipRanks’ Stock Analysis page.